Synergistic inhibitory effect of sulforaphane and 5-fluorouracil in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma

Phytotherapy Research

Volumn 23, Issue 3, 2009, Pages 303-307

  Wang, Xiao Feng ^a,c   Wu, Dong Mei ^b   Li, Bao Xin ^c   Lu, Yan Jie ^c   Yang, Bao Feng ^c,d  

^a Medical University   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d State Environmental Protection Key Laboratory of Sources and Control of Air Pollution Complex   (China)

Author keywords

5 fluorouracil; Adenoid cystic carcinoma; Nf b; Sulforaphane; Synergistic suppression

Indexed keywords

FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SULFORAPHANE; TRANSCRIPTION FACTOR RELA;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS POTENTIAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; DRUG COMBINATIONS; DRUG SYNERGISM; FLUOROURACIL; HUMANS; SALIVARY GLAND NEOPLASMS; THIOCYANATES; TRANSCRIPTION FACTOR RELA;

EID: 61449231592     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2618     Document Type: Article

References (26)

1. Aota K, Azuma M, Yamashita T, Tamatani T, Motegi K, Ishimaru N, Hayashi Y, Sato M. 2000. 5-Fluorouracil induces apoptosis through the suppression of NF-kappaB activity in human salivary gland cancer cells. Biochem Biophys Res Comm 273: 1168-1174.
2. Barutca S, Ceyhan C, Meydan N, Ozturk B, Tekten T, Onbasili A, Kadikoylu G, Bolaman Z. 2004. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen. Chemotherapy 50: 113-118.
3. Bours V, Bentires-AljM, Hellin AC, Vlatour P, Robe P, Delhalle S, Benoit V, Merville, MP. 2000. Nuclear factor-kappaB, cancer and apoptosis. Biochem Pharmacol 60: 1085-1089.
4. Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV. 2007. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis 28: 151-162.
5. Chou TC, Motzer RJ, Tong Y, Bosl GJ. 1994. Computerized quantitation of synergism and antagonism of Taxol, topotecan and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 86: 1517-1524.
6. Chou TC, Talalay P. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55.
7. Dodd RL, Slevin NJ. 2006. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42: 759-769.
8. Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A. 2007. The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol) 19: 154-161.
9. Fimognari C, Hrelia P. 2007. Sulforaphane as a promising molecule for fighting cancer. Mutat Res 635: 90-104.
10. Fordice J, Kershaw C, El-Naggar A, Goepfert H. 1999. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 125:149-152.
11. Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ. 2003. Function of nuclear factor kappaB in pancreatic cancer metastasis. Clin Cancer Res 9: 346-354.
12. Guan XF, Qiu WL, He RG, Zhou XJ. 1997. Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg 26: 116-119.
13. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäuser C. 2001. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276: 32008-32015.
14. Jeong WS, Kim IW, Hu R, Kong AN. 2004. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 21: 661-670.
15. J, Minnich DJ, Camp ER, Brank A, Mackay SL, Hochwald SN. 2006. Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB. J Surg Res 132: 112-120.
16. Natarajan K, Manna SK, Chaturvedi MM, Aggarwal BB. 1998. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression. Arch Biochem Biophys352: 59-70.
17. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Fernandez-Salguero PM. 2005. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 115:74-84.
18. Shishodia S, Amin HM, Lai R, Aggarwal BB. 2005. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70: 700-713.
19. Sun Z, Andersson R. 2002. NF-kappaB activation and inhibition: a review. Shock 18: 99-106.
20. Wadsworth TL, Koop DR. 1999. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 57: 941-949.
21. Wang W, Cassidy J, O'Brien V, Ryan KM, Collie-Duguid E. 2004. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells. Cancer Res 64: 8167-8176.
22. Wu JT, Kral JG. 2005. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 123: 158-169.
23. Xu C, Shen G, Chen C, Gélinas C, Kong AN. 2005. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24: 4486-4495.
24. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. 2002. The role of nitric oxide in cancer. Cell Res 12: 311-320.
25. Zhang J, Peng B, Chen X. 2005. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11: 7334-7343.
26. Zhang J, Peng B. 2007. In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma. BMC Cancer 7: 95.